Health ❯Diabetes ❯Type 2 Diabetes

Treatment Options

GLP-1 Agonists GLP-1 Medications GLP-1 Receptor Agonists Clinical Trials Mounjaro vs Ozempic Ozempic Semaglutide CagriSema Oral Medications Orforglipron Wegovy Rybelsus Weight Loss Medications Weight Loss Injections Elenolic Acid Weight Management Medications Injectable Medications GLP-1 Drugs

4 ARTICLES

3mo ago

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

Novo Nordisk files for FDA approval of its oral anti-obesity medication, following Eli Lilly's phase III success with orforglipron, the first oral GLP-1 to achieve this milestone.

5 ARTICLES

4mo ago

Novo Nordisk Urges FDA to Ban Compounded Versions of Ozempic and Wegovy

Treatment Options

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

Novo Nordisk Acquires Chinese Obesity Drug After CagriSema Trial Disappointment

Eli Lilly Launches Mounjaro in India to Address Obesity and Diabetes

FDA Approves Ozempic to Reduce Kidney Disease Risks in Type 2 Diabetes Patients

Novo Nordisk Urges FDA to Ban Compounded Versions of Ozempic and Wegovy